Publications by authors named "N M Galeeva"

Multiple osteochondromas (MO) is a rare autosomal dominant skeletal disorder characterized by the development of multiple benign tumors known as osteochondromas. The condition is predominantly caused by loss-of-function variants in the or genes, facilitating relatively precise clinical diagnosis through established diagnostic criteria. Despite this, a notable percentage of MO cases (10%-20%) remains unresolved after sequencing coding regions and copy number analysis of both genes.

View Article and Find Full Text PDF

Congenital and early onset bilateral sensorineural hearing loss (SNHL) is mainly caused by mutations in numerous genes. The introduction of universal newborn hearing screening (UNHS) has increased the number of infants with mild, moderate, and moderate-to-severe sensorineural hearing loss (SNHL) detected in the first year of life. We aimed to evaluate the audiological features in patients with mild, moderate, and moderate-to-severe SNHL according to genotype.

View Article and Find Full Text PDF

Hearing loss is one of the most genetically heterogeneous disorders known. Over 120 genes are reportedly associated with non-syndromic hearing loss (NSHL). To date, in Russia, there have been relatively few studies that apply massive parallel sequencing (MPS) methods to elucidate the genetic factors underlying non-GJB2-related hearing loss cases.

View Article and Find Full Text PDF

Introduction: Nowadays, due to universal newborn hearing screening (UNHS) the number of children with mild-to-moderate hearing loss diagnosed in the first year of life has increased significantly. Aside from that, identification of the genetic cause improves the genetic counselling of the families and allows to reveal possible comorbidities which may need a special approach.

Objective: To present the characteristics of the early audiologic phenotype in hearing impaired patients with biallelic mutations in the USH2A gene based on systematic analysis of the audiological data.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed 116 patients with COVID-19-associated pneumonia, dividing them into two groups: 49 without cardiovascular diseases (CVD) and 67 with CVD, investigating various blood parameters and inflammation biomarkers at hospitalization and three months post-discharge.
  • Key findings included that certain inflammatory and hemostatic markers like CRP, ESR, and WBC remained elevated in the CVD group, indicating a persistent inflammatory state even after recovery compared to those without CVD.
  • Correlation analysis showed a link between inflammation markers and the extent of lung damage, emphasizing the importance of monitoring these biomarkers for predicting disease progression in CVD patients facing COVID-19-associated pneumonia.
View Article and Find Full Text PDF